Skip to content

Surgeon-Guided Serratus Block in Breast Reduction Surgery

Postoperative Analgesic Efficacy of Intraoperative Surgeon-Guided Serratus Block: A Prospective Randomized Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06905574
Enrollment
60
Registered
2025-04-01
Start date
2024-12-01
Completion date
2025-10-31
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reduction, Postoperative Pain Control

Keywords

breast reduction, postoperative pain control

Brief summary

Surgeon guided serratus block, which can be performed by the surgeon in participants undergoing breast reduction surgery, may reduce the sensation of pain from the surgical field in the postoperative period. Thus, participants experience less pain in the postoperative period, consume less analgesics, and there is a decrease in related complications. The aim of this study was to evaluate the effects of the intraoperative surgeon guided serratus block applied on the analgesic consumption of the participants in the first 24 hours after surgery in participants undergoing breast reduction surgery.

Interventions

OTHERsurgeon guided serratus block

Surgeon guided Serratus Block will be applied before closing dermoglandular flaps

Sponsors

alperen can kokten
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient's willingness to be included in the study * 18-65 years * Woman * Operated with inferior pedicled breast reduction technique * The distance from the sternal notch to the nipple complex is between 25-40cm * ASA I-II * Breast Usg result BIRADS 1-2 * Patients who have not previously received RT to the breast and have no history of malignancy

Exclusion criteria

* Patient's request/refusal not to be included in the study * Previous history of malignancy * RT story, * ASA 3-4-5-patient group * Severe organ failure * Alcohol, drug addiction * Bupivacaine allergy * Diagnosis of psychiatric illness and psychiatric drug use * Surgery lasting longer than 3 hours * Bleeding diathesis

Design outcomes

Primary

MeasureTime frameDescription
24 hours postoperatively opioid consumption24 hoursIn the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected and compared between groups.

Secondary

MeasureTime frameDescription
post-operative acute pain status, post-operative nausea-vomiting status, post-operative NRS determination of pain at rest and in motion determination of complications such as nausea, vomiting, itching, determination of the first PCA analgesic request.24 hoursChanges in the Numerical Rating Scale (NRS) will be recorded at rest and during movement. The participant's baseline NRS will be recorded, followed by measurements before and after neuraxial positioning and up to 24 hours post-surgery. The NRS is a unidimensional measure of pain intensity in adults. The 11-point numerical scale ranges from '0' representing one end of the pain spectrum (e.g. 'no pain') to '10' representing the other end (e.g. 'worst imaginable pain').

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORAyhan Sönmez

SAMSUN UNİVERSİTY

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026